CTLA4 and central nervous system cancer: For example, Dipongkor Saha et al. reported that combining anti-CTLA-4, anti-PD-1, and G47Δ-mIL12 in glioma models significantly enhanced M1-like polarization and elevated the ratio of effector T cells to regulatory T cells [346].